Cardiac sarcoidosis: A long term follow up study.

Patrice CacoubCatherine Chapelon-AbricMatthieu Resche-RigonDavid SaadounAnne Claire DesboisLucie Biard

Published in: PloS one (2020)

Our study identifies putative factors affecting morbidity and mortality in cardiac sarcoidosis patients. Intravenous cyclophosphamide is associated with lower relapse rates.

Keyphrases

end stage renal disease
high dose
chronic kidney disease
ejection fraction
low dose
peritoneal dialysis
patient reported